Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Salesforce, Inc. Director's Dealing 2024

Oct 16, 2024

29776_dirs_2024-10-16_cf711fec-ecaa-4a30-a281-426a9974ba15.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Salesforce, Inc. (CRM)
CIK: 0001108524
Period of Report: 2024-10-15

Reporting Person: Harris Parker (Director, Co-Founder and CTO, Slack)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-10-15 Common Stock M 4200 $118.04 Acquired 122714 Direct
2024-10-15 Common Stock S 1455 $288.598 Disposed 121259 Direct
2024-10-15 Common Stock S 1471 $290.0099 Disposed 119788 Direct
2024-10-15 Common Stock S 948 $290.6805 Disposed 118840 Direct
2024-10-15 Common Stock S 123 $291.5863 Disposed 118717 Direct
2024-10-15 Common Stock S 203 $293.1957 Disposed 118514 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2024-10-15 Non-qualified Stock Option (Right to Buy) $118.04 M 4200 Disposed 2025-03-22 Common Stock (4200) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 946987 Indirect
Common Stock 115840 Indirect
Common Stock 171323 Indirect
Common Stock 115840 Indirect
Common Stock 171324 Indirect
Common Stock 115840 Indirect
Common Stock 171324 Indirect

Footnotes

F1: As indicated by the checkbox above, this transaction was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 26, 2023.

F2: Weighted average price. These shares were sold in multiple transactions at prices ranging from $288.2100 to $289.1500 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

F3: Weighted average price. These shares were sold in multiple transactions at prices ranging from $289.3800 to $290.3600 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

F4: Weighted average price. These shares were sold in multiple transactions at prices ranging from $290.3900 to $290.9900 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

F5: Weighted average price. These shares were sold in multiple transactions at prices ranging from $291.5800 to $291.6000 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

F6: Weighted average price. These shares were sold in multiple transactions at prices ranging from $292.7400 to $293.4800 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

F7: Shares held in The G. Parker Harris III & Holly L. Johnson Family Trust.

F8: The reported securities are held by an LLC that is managed by the reporting person and his spouse.

F9: Option is exercisable and vests over four years at the rate of 25% on March 22, 2019, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months.